In this study, through unsupervised clustering of the DDR-related expression profiles of HCC samples, we found that HCC patients could be divided into a DDR1 group (with low activation of DDR pathways) and a DDR2 group (with high activation of DDR pathways). Here, DDR2 is linked to hepatocellular carcinoma.